Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Rindopepimut |
| Trade Name | |
| Synonyms | CDX-110|PF-04948568 |
| Drug Descriptions |
Rindopepimut (CDX-110) is a peptide vaccine that targets EGFRvIII, which may stimulate immune response against EGFRvIII-expressing cells (PMID: 32034072). |
| DrugClasses | |
| CAS Registry Number | 946156-74-7 |
| NCIT ID | C69076 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + Rindopepimut | Bevacizumab Rindopepimut | 0 | 0 |
| Rindopepimut | Rindopepimut | 0 | 0 |